|
The Collagenomics® series is a collagen peptide that is rich in peptides that are stably and highly absorbed in the body after ingestion. The positive effects of oral ingestion of collagen peptide (or gelatin) have long been known. Collagen is a type of protein that was believed to be absorbed as an amino acid. In 2005,
a group led by Professor Kenji Sato of Kyoto Prefectural University (currently Kyoto University) found that orally ingested collagen peptides were not all absorbed as amino acids; some were detected in the blood
as peptides. This changed the way we think about protein nutrition. Furthermore, it has become clear that the peptides detected in the blood are Hyp-containing di- and tripeptides such as Pro-Hyp and
Ala-Hyp-Gly, and these functions have been reported one after another. At present, these are considered to be functional factors for the effect of oral intake of collagen peptide. Collagen peptides are generally made by breaking down collagen using proteolytic enzymes. Therefore, Nippi worked on the development of a manufacturing method that contains the active peptide, which is a functional factor, in advance. Due to severe restrictions on food manufacturing enzymes, it was difficult to produce the desired peptide, but thanks to the Nippi Research Institute of Biomatrix’s basic research results, it was commercialized as the Collagenomics® series. The peptides standardized in the Collagenomics® series are active peptides that are stable in the blood and can reach the required site.
|